210 related articles for article (PubMed ID: 27863292)
1. Mechanical abnormalities associated with first- and second-generation drug-eluting stent thrombosis analyzed by optical coherence tomography in the national PESTO French registry.
Amabile N; Trouillet C; Meneveau N; Tissot CM; Belle L; Combaret N; Range G; Pansieri M; Delaunay R; Levesque S; Lhermusier T; Derimay F; Motreff P; Caussin C; Souteyrand G
Int J Cardiol; 2017 Jan; 227():161-165. PubMed ID: 27863292
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry.
Souteyrand G; Amabile N; Mangin L; Chabin X; Meneveau N; Cayla G; Vanzetto G; Barnay P; Trouillet C; Rioufol G; Rangé G; Teiger E; Delaunay R; Dubreuil O; Lhermusier T; Mulliez A; Levesque S; Belle L; Caussin C; Motreff P;
Eur Heart J; 2016 Apr; 37(15):1208-16. PubMed ID: 26757787
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
[TBL] [Abstract][Full Text] [Related]
4. Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort).
Adriaenssens T; Joner M; Godschalk TC; Malik N; Alfonso F; Xhepa E; De Cock D; Komukai K; Tada T; Cuesta J; Sirbu V; Feldman LJ; Neumann FJ; Goodall AH; Heestermans T; Buysschaert I; Hlinomaz O; Belmans A; Desmet W; Ten Berg JM; Gershlick AH; Massberg S; Kastrati A; Guagliumi G; Byrne RA;
Circulation; 2017 Sep; 136(11):1007-1021. PubMed ID: 28720725
[TBL] [Abstract][Full Text] [Related]
5. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.
Nakazawa G; Finn AV; Vorpahl M; Ladich ER; Kolodgie FD; Virmani R
J Am Coll Cardiol; 2011 Jan; 57(4):390-8. PubMed ID: 21251578
[TBL] [Abstract][Full Text] [Related]
6. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
[TBL] [Abstract][Full Text] [Related]
7. Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials.
Cassese S; Xhepa E; Ndrepepa G; Kufner S; Colleran R; Giacoppo D; Koppara T; Mankerious N; Byrne RA; Laugwitz KL; Schunkert H; Fusaro M; Kastrati A; Joner M
Eur Heart J Cardiovasc Imaging; 2018 Nov; 19(11):1294-1301. PubMed ID: 29300853
[TBL] [Abstract][Full Text] [Related]
8. Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis.
Nakamura D; Attizzani GF; Toma C; Sheth T; Wang W; Soud M; Aoun R; Tummala R; Leygerman M; Fares A; Mehanna E; Nishino S; Fung A; Costa MA; Bezerra HG
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582113
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography.
Taniwaki M; Radu MD; Zaugg S; Amabile N; Garcia-Garcia HM; Yamaji K; Jørgensen E; Kelbæk H; Pilgrim T; Caussin C; Zanchin T; Veugeois A; Abildgaard U; Jüni P; Cook S; Koskinas KC; Windecker S; Räber L
Circulation; 2016 Feb; 133(7):650-60. PubMed ID: 26762519
[TBL] [Abstract][Full Text] [Related]
11. IVUS Findings in Late and Very Late Stent Thrombosis. A Comparison Between Bare-metal and Drug-eluting Stents.
Fuentes L; Gómez-Lara J; Salvatella N; Gonzalo N; Hernández-Hernández F; Fernández-Nofrerias E; Sánchez-Recalde Á; Alfonso F; Romaguera R; Ferreiro JL; Roura G; Teruel L; Gracida M; Marcano AL; Gómez-Hospital JA; Cequier Á
Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):335-343. PubMed ID: 28870640
[TBL] [Abstract][Full Text] [Related]
12. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
13. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
[TBL] [Abstract][Full Text] [Related]
14. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
[TBL] [Abstract][Full Text] [Related]
15. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis.
Shimamura K; Kubo T; Akasaka T; Kozuma K; Kimura K; Kawamura M; Sumiyoshi T; Ino Y; Yoshiyama M; Sonoda S; Igarashi K; Miyazawa A; Uzui H; Sakanoue Y; Shinke T; Morino Y; Tanabe K; Kadota K; Kimura T
Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):23-8. PubMed ID: 25342855
[TBL] [Abstract][Full Text] [Related]
17. OCT Analysis of Very Early Strut Coverage of the Synergy Stent in Non-ST Segment Elevation Acute Coronary Syndrome Patients.
Laine M; Dabry T; Combaret N; Motreff P; Puymirat E; Paganelli F; Thuny F; Cautela J; Peyrol M; Mancini J; Lemesle G; Bonello L
J Invasive Cardiol; 2019 Jan; 31(1):10-14. PubMed ID: 30418164
[TBL] [Abstract][Full Text] [Related]
18. Relationship between aspirin/clopidogrel resistance and intra-stent thrombi assessed by follow-up optical coherence tomography after drug-eluting stent implantation.
Park J; Shin DH; Kim BK; Her AY; Kim YH; Choi HH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1181-6. PubMed ID: 23657678
[TBL] [Abstract][Full Text] [Related]
19. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
Novack V; Cutlip D; Kleiman N; Pencina M; Mauri L; Yen CH; Berger P; Goldberg S; Kellett M; Waksman R; Hong M; Raizner AE; Cohen DJ
JACC Cardiovasc Interv; 2009 Aug; 2(8):767-75. PubMed ID: 19695546
[TBL] [Abstract][Full Text] [Related]
20. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
